Telomeres, telomerase, and hematopoietic stem cell biology

Archives of Medical Research

Volumn 34, Issue 6, 2003, Pages 489-495

  Greenwood, Matthew J ^a   Lansdorp, Peter M ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b BRITISH COLUMBIA CANCER AGENCY   (Canada)

Author keywords

Dyskeratosis congenita; Hematopoietic stem cell; Telomerase; Telomere

Indexed keywords

TELOMERASE;

APLASTIC ANEMIA; CELL FUNCTION; DYSKERATOSIS CONGENITA; HEMATOPOIETIC STEM CELL; HUMAN; REGULATORY MECHANISM; REVIEW; TELOMERE; TRANSCRIPTION REGULATION;

EID: 0346374776     PISSN: 01884409     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcmed.2003.07.003     Document Type: Review

References (63)

1. Blackburn E.H. Switching and signaling at the telomere. Cell. 106:2001;661-673.
2. n, present at the telomeres of human chromosomes. Proc Natl Acad Sci USA. 85:1988;6622-6626.
3. McEachern M.J., Krauskopf A., Blackburn E.H. Telomeres and their control. Annu Rev Genet. 34:2000;331-358.
4. Baumann P., Podell E., Cech T.R. Human Pot1 (protection of telomeres) protein: cytolocalization, gene structure, and alternative splicing. Mol Cell Biol. 22:2002;8079-8087.
5. de Lange T. Protection of mammalian telomeres. Oncogene. 21:2002;532-540.
6. Griffith J.D., Comeau L., Rosenfield S., Stansel R.M., Bianchi A., Moss H., de Lange T. Mammalian telomeres end in a large duplex loop. Cell. 97:1999;503-514.
7. Karlseder J., Broccoli D., Dai Y., Hardy S., de Lange T. p53- and ATM-dependent apoptosis induced by telomeres lacking TRF2. Science. 283:1999;1321-1325.
8. Stewart S.A., Ben Porath I., Carey V.J., O'Connor B.F., Hahn W.C., Weinberg R.A. Erosion of the telomeric single-strand overhang at replicative senescence. Nat Genet. 33:2003;492-496.
9. Saretzki G., von Zglinicki T. Replicative aging, telomeres, and oxidative stress. Ann NY Acad Sci. 959:2002;24-29.
10. Ohki R., Tsurimoto T., Ishikawa F. In vitro reconstitution of the end replication problem. Mol Cell Biol. 21:2001;5753-5766.
11. Allsopp R.C., Weissman I.L. Replicative senescence of hematopoietic stem cells during serial transplantation: does telomere shortening play a role? Oncogene. 21:2002;3270-3273.
12. Watson J.D. Origin of concatameric T4 DNA. Nat New Biol. 239:1972;197-201.
13. Olovnikov A.M. A theory of marginotomy. The incomplete copying of template margin in enzymic synthesis of polynucleotides and biological significance of the phenomenon. J Theor Biol. 41:1973;181-190.
14. Dionne I., Wellinger R.J. Processing of telomeric DNA ends requires the passage of a replication fork. Nucleic Acids Res. 26:1998;5365-5371.
15. von Zglinicki T., Saretzki G., Docke W., Lotze C. Mild hyperoxia shortens telomeres and inhibits proliferation of fibroblasts: a model for senescence? Exp Cell Res. 220:1995;186-193.
16. Proctor C.J., Kirkwood T.B. Modelling telomere shortening and the role of oxidative stress. Mech Ageing Dev. 123:2002;351-363.
17. Henson J.D., Neumann A.A., Yeager T.R., Reddel R.R. Alternative lengthening of telomeres in mammalian cells. Oncogene. 21:2002;598-610.
18. Schnapp G., Rodi H.P., Rettig W.J., Schnapp A., Damm K. One-step affinity purification protocol for human telomerase. Nucleic Acids Res. 26:1998;3311-3313.
19. Yu G.L., Bradley J.D., Attardi L.D., Blackburn E.H. In vivo alteration of telomere sequences and senescence caused by mutated Tetrahymena telomerase RNAs. Nature. 344:1990;126-132.
20. Weinrich S.L., Pruzan R., Ma L., Ouellette M., Tesmet V.M., Hull S.E. Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT. Nat Genet. 17:1997;498-502.
21. Collins K., Mitchell J.R. Telomerase in the human organism. Oncogene. 21:2002;564-579.
22. Wright W.E., Piatyszek M.A., Rainey W.E., Byrd W., Shay J.W. Telomerase activity in human germline and embryonic tissues and cells. Dev Genet. 18:1996;173-179.
23. Horikawa I., Barrett J.C. Transcriptional regulation of the telomerase hTERT gene as a target for cellular and viral oncogenic mechanisms. Carcinogenesis. 24:(7):2003;1167-1176.
24. Wang J., Xie L.Y., Allan S., Beach D., Hannon G.J. Myc activates telomerase. Genes Dev. 12:1998;1769-1774.
25. Lee S.B., Haber D.A. Wilms tumor and the WT1 gene. Exp Cell Res. 264:2001;74-99.
26. Aisner D.L., Wright W.E., Shay J.W. Telomerase regulation: not just flipping the switch. Curr Opin Genet Dev. 12:2002;80-85.
27. Mitchell J.R., Cheng J., Collins K. A box H/ACA small nucleolar RNA-like domain at the human telomerase RNA 3′ end. Mol Cell Biol. 19:1999;567-576.
28. Etheridge K.T., Banik S.S., Armbruster B.N., Zhu Y., Terns R.M., Terns M.P., Counter C.M. The nucleolar localization domain of the catalytic subunit of human telomerase. J Biol Chem. 277:2002;24764-24770.
29. Wong J.M., Kusdra L., Collins K. Subnuclear shuttling of human telomerase induced by transformation and DNA damage. Nat Cell Biol. 4:2002;731-736.
30. Ray S., Karamysheva Z., Wang L., Shippen D.E., Price C.M. Interactions between telomerase and primase physically link the telomere and chromosome replication machinery. Mol Cell Biol. 22:2002;5859-5868.
31. Reichenbach P., Hoss M., Azzalin C.M., Nabholz M., Bucher P., Lingner J. A human homolog of yeast est1 associates with telomerase and uncaps chromosome ends when overexpressed. Curr Biol. 13:2003;568-574.
32. Cooke H.J., Smith B.A. Variability at the telomeres of the human X/Y pseudoautosomal region. Cold Spring Harbor Symp Quant Biol. 51:1986;213-219.
33. Vaziri H., Schachter F., Uchida I., Wei L., Zhu X., Effros R., Cohen D., Harley C.B. Loss of telomeric DNA during aging of normal and trisomy 21 human lymphocytes. Am J Hum Genet. 52:1993;661-667.
34. Hastie N.D., Dempster M., Dunlop M.G., Thompson A.M., Green D.K., Allshire R.C. Telomere reduction in human colorectal carcinoma and with ageing. Nature. 346:1990;866-868.
35. Vaziri H., Dragowska W., Allsopp R.C., Thomas T.E., Harley C.B., Lansdorp P.M. Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age. Proc Natl Acad Sci USA. 91:1994;9857-9860.
36. Rufer N., Brummendorf T.H., Kolvraa S., Bischoff C., Christensen K., Wadsworth L., Schultzer M., Lansdorp P.M. Telomere fluorescence measurements in granulocytes and T lymphocyte subsets point to a high turnover of hematopoietic stem cells and memory T cells in early childhood. J Exp Med. 190:1999;157-167.
37. Baerlocher G.M., Mak J., Tien T., Lansdorp P.M. Telomere length measurements by fluorescence in situ hybridization and flow cytometry: tips and pitfalls. Cytometry. 47:2002;89-99.
38. Slagboom P.E., Droog S., Boomsma D.I. Genetic determination of telomere size in humans: a twin study of three age groups. Am J Hum Genet. 55:1994;876-882.
39. Harrison D.E., Astle C.M. Loss of stem cell repopulating ability upon transplantation. Effects of donor age, cell number, and transplantation procedure. J Exp Med. 156:1982;1767-1779.
40. Allsopp R.C., Cheshier S., Weissman I.L. Telomere shortening accompanies increased cell cycle activity during serial transplantation of hematopoietic stem cells. J Exp Med. 193:2001;917-924.
41. Rufer N., Brummendorf T.H., Chapuis B., Helg C., Lansdorp P.M., Roosnek E. Accelerated telomere shortening in hematological lineages is limited to the first year following stem cell transplantation. Blood. 97:2001;575-577.
42. Brummendorf T.H., Rufer N., Baerlocher G.M., Roosnek E., Lansdorp P.M. Limited telomere shortening in hematopoietic stem cells after transplantation. Ann NY Acad Sci. 938:2001;1-8.
43. Wynn R.F., Cross M.A., Hatton C., Will A.M., Lashford L.S., Dexter T.M., Testa N.G. Accelerated telomere shortening in young recipients of allogeneic bone-marrow transplants. Lancet. 351:1998;178-181.
44. Robertson J.D., Testa N.G., Russell N.H., Jackson G., Parker A.N., Milligan D.W., Stainer C., Chakrabarti S., Dougal M., Chopra R. Accelerated telomere shortening following allogeneic transplantation is independent of the cell source and occurs within the first year post transplant. Bone Marrow Transplant. 27:2001;1283-1286.
45. Brummendorf T.H., Holyoake T.L., Rufer N., Barnett M.J., Schulzer M., Eaves C.J., Eaves A.C., Lansdorp P.M. Prognostic implications of differences in telomere length between normal and malignant cells from patients with chronic myeloid leukemia measured by flow cytometry. Blood. 95:2000;1883-1890.
46. Ohyashiki J.H., Sashida G., Tauchi T., Ohyashiki K. Telomeres and telomerase in hematologic neoplasia. Oncogene. 21:2002;680-687.
47. Morrison S.J., Prowse K.R., Ho P., Weissman I.L. Telomerase activity in hematopoietic cells is associated with self-renewal potential. Immunity. 5:1996;207-216.
48. Engelhardt M., Kumar R., Albanell J., Pettengell R., Han W., Moore M.A. Telomerase regulation, cell cycle, and telomere stability in primitive hematopoietic cells. Blood. 90:1997;182-193.
49. Broccoli D., Young J.W., de Lange T. Telomerase activity in normal and malignant hematopoietic cells. Proc Natl Acad Sci USA. 92:1995;9082-9086.
50. Chiu C.-P., Dragowska W., Kim N.W., Vaziri H., Yui J., Thomas T.E., Harley C.B., Lansdorp P.M. Differential expression of telomerase activity in hematopoietic progenitors from adult human bone marrow. Stem Cells. 14:1996;239-248.
51. Szyper-Kravitz M., Uziel O., Shapiro H., Radnay J., Katz T., Rowe J.M., Lishner M., Lahav M. Granulocyte colony-stimulating factor administration upregulates telomerase activity in CD34+ haematopoietic cells and may prevent telomere attrition after chemotherapy. Br J Haematol. 120:2003;329-336.
52. Allsopp R.C., Morin G.B., DePinho R., Harley C.B., Weissman I.L. Telomerase is required to slow telomere shortening and extend replicative lifespan of HSCs during serial transplantation. Blood. 102:2003;517-520.
53. Marrone A., Mason P.J. Dyskeratosis congenita. Cell Mol Life Sci. 60:2003;507-517.
54. Mason P.J. Stem cells, telomerase and dyskeratosis congenita. Bioessays. 25:2003;126-133.
55. Lansdorp P.M. Lessons from mice without telomerase. J Cell Biol. 139:1997;309-312.
56. Samper E., Fernández P., Eguia R., Martín-Rivera L., Bernad A., Blasco M.A., Aracil M. Long-term repopulating ability of telomerase-deficient murine hematopoietic stem cells. Blood. 99:2002;2767-2775.
57. Burt R.K., Deeg H.J. Aplastic anemia. Lothian S.T., Santos G.W. Bone marrow transplantation. 1996;154-161 R.G. Landes & Co, Georgetown, TX, USA.
58. Vulliamy T., Marrone A., Dokal I., Mason P.J. Association between aplastic anaemia and mutations in telomerase RNA. Lancet. 359:2002;2168-2170.
59. Ball S.E., Gibson F.M., Rizzo S., Tooze J.A., Marsh J.C.W., Gordon-Smith E.C. Progressive telomere shortening in aplastic anemia. Blood. 91:1998;3582-3592.
60. Brummendorf T.H., Rufer N., Holyoake T.L., Maciejewski J., Barnett M.J., Eaves C.J., Eaves A.C., Young N., Lansdorp P.M. Telomere length dynamics in normal individuals and in patients with hematopoietic stem cell-associated disorders. Ann NY Acad Sci. 938:2001;293-304.
61. Lee J.J., Kook H., Chung I.J., Na J.A., Park M.R., Hwang T.J., Kwak J.Y., Sohn S.K., Kim H.J. Telomere length changes in patients with aplastic anaemia. Br J Haematol. 112:2001;1025-1030.
62. Brummendorf T.H., Maciejewski J.P., Mak J., Young N.S., Lansdorp P.M. Telomere length in leukocyte subpopulations of patients with aplastic anemia. Blood. 97:2001;895-900.
63. Yamaguchi H., Baerlocher G.M., Lansdorp P.M., Chanock S.J., Núñez O., Sloand E., Young N.S. Mutations of the human telomerase RNA gene (hTERC) in aplastic anemia and myelodysplastic syndrome. Blood. 102:(3):2003;916-918.